These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1389481)

  • 1. High-dose rapid schedule chemotherapy for disseminated neuroblastoma.
    Pearson AD; Craft AW; Pinkerton CR; Meller ST; Reid MM
    Eur J Cancer; 1992; 28A(10):1654-9. PubMed ID: 1389481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-intensive use of cyclophosphamide in ablation of neuroblastoma.
    Kushner BH; O'Reilly RJ; LaQuaglia M; Cheung NK
    Cancer; 1990 Sep; 66(6):1095-100. PubMed ID: 2400963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
    Kushner BH; LaQuaglia MP; Bonilla MA; Lindsley K; Rosenfield N; Yeh S; Eddy J; Gerald WL; Heller G; Cheung NK
    J Clin Oncol; 1994 Dec; 12(12):2607-13. PubMed ID: 7527454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
    Kushner BH; Kramer K; LaQuaglia MP; Modak S; Yataghene K; Cheung NK
    J Clin Oncol; 2004 Dec; 22(24):4888-92. PubMed ID: 15611504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
    Rubie H; Michon J; Plantaz D; Peyroulet MC; Coze C; Frappaz D; Chastagner P; Baranzelli MC; Méchinaud F; Boutard P; Lutz P; Perel Y; Leverger G; de Lumley L; Millot F; Stéphan JL; Margueritte G; Hartmann O
    Br J Cancer; 1998 Jun; 77(12):2310-7. PubMed ID: 9649151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.
    Pinkerton CR; Zucker JM; Hartmann O; Pritchard J; Broadbent V; Morris-Jones P; Breatnach F; Craft AE; Pearson AD; Wallendszus KR
    Br J Cancer; 1990 Aug; 62(2):319-23. PubMed ID: 2386751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential cisplatin/VM-26 and vincristine/cyclophosphamide/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross-resistant regimen?
    Bernard JL; Philip T; Zucker JM; Frappaz D; Robert A; Margueritte G; Boilletot A; Philippe N; Lutz P; Roche H
    J Clin Oncol; 1987 Dec; 5(12):1952-9. PubMed ID: 3681378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7).
    Mora J; Cruz O; Lavarino C; Rios J; Vancells M; Parareda A; Salvador H; Suñol M; Carrasco R; Guillen A; Mañé S; de Torres C
    Clin Transl Oncol; 2015 Jul; 17(7):521-9. PubMed ID: 25596034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
    Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitro.
    Kushner BH; Gulati SC; O'Reilly RJ; Heller G; Cheung NK
    Med Pediatr Oncol; 1990; 18(6):454-8. PubMed ID: 2135871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
    Yoneda A; Shichino H; Hishiki T; Matsumoto K; Ohira M; Kamijo T; Kuroda T; Soejima T; Nakazawa A; Takimoto T; Yokota I; Teramukai S; Takahashi H; Fukushima T; Hara J; Kaneko M; Ikeda H; Tajiri T; Mugishima H; Nakagawara A
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30976. PubMed ID: 38577760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma].
    Feng C; Tang SQ; Wang JW; Liu Y; Yang G
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):885-7. PubMed ID: 20113653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.
    Coze C; Hartmann O; Michon J; Frappaz D; Dusol F; Rubie H; Plouvier E; Leverger G; Bordigoni P; Béhar C; Beck D; Mechinaud F; Bergeron C; Plantaz D; Otten J; Zucker JM; Philip T; Bernard JL
    J Clin Oncol; 1997 Dec; 15(12):3433-40. PubMed ID: 9396394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
    Tweddle DA; Pinkerton CR; Lewis IJ; Ellershaw C; Cole M; Pearson AD
    Med Pediatr Oncol; 2001 Jan; 36(1):239-42. PubMed ID: 11464894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK; Kushner BH; LaQuaglia M; Kramer K; Gollamudi S; Heller G; Gerald W; Yeh S; Finn R; Larson SM; Wuest D; Byrnes M; Dantis E; Mora J; Cheung IY; Rosenfield N; Abramson S; O'Reilly RJ
    Med Pediatr Oncol; 2001 Jan; 36(1):227-30. PubMed ID: 11464891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single institution experience with high-dose cyclophosphamide, continuous infusion vincristine, escalating doses of VP-16-213, and total body irradiation with unpurged bone marrow rescue in children with neuroblastoma.
    Kletzel M; Becton DL; Berry DH
    Med Pediatr Oncol; 1992; 20(1):64-7. PubMed ID: 1530757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.